X
IDXX icon

Xponance’s Idexx Laboratories IDXX Stock Holding History

Xponance’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Sell
25,318
-1,320
-5% -$740K 0.08% 193
2026
Q1 		$15M Buy
26,638
+2,297
+9% +$1.47M 0.11% 159
2025
Q4 		$16.5M Buy
24,341
+852
+4% +$580K 0.12% 125
2025
Q3 		$15M Sell
23,489
-153
-0.6% -$92.9K 0.12% 134
2025
Q2 		$12.7M Buy
23,642
+424
+2% +$203K 0.11% 157
2025
Q1 		$9.75M Buy
23,218
+240
+1% +$104K 0.09% 172
2024
Q4 		$9.5M Buy
22,978
+4,139
+22% +$1.82M 0.09% 183
2024
Q3 		$9.52M Sell
18,839
-232
-1% -$113K 0.09% 173
2024
Q2 		$9.29M Buy
19,071
+122
+0.6% +$61.2K 0.1% 157
2024
Q1 		$10.2M Buy
18,949
+47
+0.2% +$25.7K 0.11% 160
2023
Q4 		$10.5M Sell
18,902
-252
-1% -$118K 0.13% 136
2023
Q3 		$8.38M Buy
19,154
+264
+1% +$132K 0.11% 153
2023
Q2 		$9.49M Buy
18,890
+430
+2% +$206K 0.13% 130
2023
Q1 		$9.23M Buy
18,460
+238
+1% +$114K 0.13% 134
2022
Q4 		$7.43M Buy
18,222
+1,409
+8% +$547K 0.12% 163
2022
Q3 		$5.48M Buy
16,813
+1,357
+9% +$498K 0.11% 174
2022
Q2 		$5.42M Sell
15,456
-1,167
-7% -$476K 0.11% 160
2022
Q1 		$9.09M Buy
16,623
+145
+0.9% +$76.3K 0.15% 120
2021
Q4 		$10.8M Buy
16,478
+1,171
+8% +$735K 0.17% 98
2021
Q3 		$9.52M Sell
15,307
-4,586
-23% -$3.08M 0.18% 97
2021
Q2 		$12.6M Sell
19,893
-1,342
-6% -$741K 0.23% 77
2021
Q1 		$10.4M Buy
21,235
+8,856
+72% +$4.44M 0.22% 84
2020
Q4 		$6.19M Buy
12,379
+148
+1% +$66.2K 0.13% 134
2020
Q3 		$4.81M Buy
12,231
+97
+0.8% +$35.9K 0.12% 155
2020
Q2 		$4.01M Buy
+12,134
New +$3.51M 0.1% 172

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Xponance's IDXX Position: Q2 2026 in Review

Xponance reduced its Idexx Laboratories (IDXX) stake by 5% in Q2 2026, selling an estimated $740K and leaving 25,318 shares worth $13.3M. The position accounts for 0.08% of the portfolio, ranked #193.

Xponance first reported a position in IDXX in Q2 2020 and has held it in 25 quarters since. The position peaked at $16.5M in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Xponance held 25,318 shares of Idexx Laboratories worth $13.3M as of Q2 2026.
  • Xponance sold 1,320 Idexx Laboratories shares in Q2 2026, an estimated $740K.
  • Idexx Laboratories made up 0.08% of Xponance's portfolio in Q2 2026, its #193 holding.
  • Xponance first reported a position in Idexx Laboratories in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Idexx Laboratories position peaked at $16.5M in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.